Tumor antigen-sensitized DC vaccine

BIOLOGICAL2 trials

Sponsors

Sichuan University, West China Hospital

Conditions

CarcinomaColorectal CancerEsophagus Cancer

Phase 1

Tumor Antigen-sensitized DC Vaccine As an Adjuvant Therapy for Esophagus Cancer

CompletedNCT05023928

Sichuan UniversityCarcinoma, Esophagus Cancer

Start: 2021-09-01End: 2024-10-30Updated: 2025-03-12

Tumor Antigen-sensitized DC Vaccine for Colorectal Cancer Liver Metastases

RecruitingNCT06545630

West China HospitalCarcinoma, Colorectal Cancer

Start: 2023-11-01End: 2026-05-31Target: 10Updated: 2024-08-09

Related Papers

Abstract 4108: Safety and feasibility of personalized neoantigen DC vaccines in postoperative esophagus squamous cell carcinoma: A Phase 1b trial

Cancer Research2024-03-223 citations